Medicine
Valsartan 40 mg tablet
Valsartan 40 mg tablet is a generic prescription medicine for oral use, made by 26 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to…
Key facts
- Active ingredient (INN)
- Valsartan
- Brand
- Sold under the generic name
- Strength
- 40 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 30 tablets, 500 tablets and 75 more
- Manufacturers
- Alembic PharmaceuticalsIndiaCamber PharmaceuticalsIndiaDr. Reddy's LaboratoriesIndiaJubilant Cadista PharmaceuticalsIndiaAscend LaboratoriesIndiaAurobindo PharmaIndiaLaurus LabsIndiaMacleods PharmaceuticalsIndia26 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C to 30°C (59°F to 86°F). Protect from moisture.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C09CA03 Valsartan
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 7 July 2014
- Identifiers
- RxCUI 349199, 349200, 349201 +1DailyMed set ID 5ee97546-2a7c-40fa-9e05-b7993a72dfbf, bd7b35c7-9f01-4afd-b497-bbe0f3d69b29, 93b82a9f-dc0a-4f7d-b0d4-4adf0d917b7e +27NDC 76483-026, 72578-131, 29300-232 +27Application ANDA205347, ANDA218991, ANDA209261 +14
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 26 labelers. The register lists 78 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 carton | 46708-044-10 | Alembic PharmaceuticalsIndia | 6 January 2015 |
| 30 tablet in 1 bottle | 46708-044-30 | Alembic PharmaceuticalsIndia | 6 January 2015 |
| 500 tablet in 1 bottle | 46708-044-71 | Alembic PharmaceuticalsIndia | 6 January 2015 |
| 90 tablet in 1 bottle | 46708-044-90 | Alembic PharmaceuticalsIndia | 6 January 2015 |
| 1000 tablet in 1 bottle | 46708-044-91 | Alembic PharmaceuticalsIndia | 6 January 2015 |
| 100 tablet in 1 carton | 62332-044-10 | Alembic PharmaceuticalsIndia | 20 May 2016 |
| 30 tablet in 1 bottle | 62332-044-30 | Alembic PharmaceuticalsIndia | 20 May 2016 |
| 500 tablet in 1 bottle | 62332-044-71 | Alembic PharmaceuticalsIndia | 20 May 2016 |
| 90 tablet in 1 bottle | 62332-044-90 | Alembic PharmaceuticalsIndia | 20 May 2016 |
| 1000 tablet in 1 bottle | 62332-044-91 | Alembic PharmaceuticalsIndia | 20 May 2016 |
| 500 tablet, film coated in 1 bottle | 31722-151-05 | Camber PharmaceuticalsIndia | 23 June 2021 |
| 30 tablet, film coated in 1 bottle | 31722-151-30 | Camber PharmaceuticalsIndia | 23 June 2021 |
| 10 tablet, film coated in 1 blister pack | 31722-151-31 | Camber PharmaceuticalsIndia | 23 June 2021 |
| 100 tablet, film coated in 1 blister pack | 31722-151-32 | Camber PharmaceuticalsIndia | 23 June 2021 |
| 90 tablet, film coated in 1 bottle | 31722-151-90 | Camber PharmaceuticalsIndia | 23 June 2021 |
| 500 tablet, film coated in 1 bottle | 31722-745-05 | Camber PharmaceuticalsIndia | 5 January 2015 |
| 30 tablet, film coated in 1 bottle | 31722-745-30 | Camber PharmaceuticalsIndia | 5 January 2015 |
| 10 tablet, film coated in 1 blister pack | 31722-745-31 | Camber PharmaceuticalsIndia | 5 January 2015 |
| 100 tablet, film coated in 1 blister pack | 31722-745-32 | Camber PharmaceuticalsIndia | 5 January 2015 |
| 90 tablet, film coated in 1 bottle | 31722-745-90 | Camber PharmaceuticalsIndia | 5 January 2015 |
| 500 tablet, film coated in 1 bottle | 67877-415-05 | Ascend LaboratoriesIndia | 14 March 2019 |
| 1000 tablet, film coated in 1 bottle | 67877-415-10 | Ascend LaboratoriesIndia | 14 March 2019 |
| 30 tablet, film coated in 1 bottle | 67877-415-30 | Ascend LaboratoriesIndia | 14 March 2019 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 65862-570-10 | Aurobindo PharmaIndia | 5 January 2015 |
| 30 tablet, film coated in 1 bottle | 65862-570-30 | Aurobindo PharmaIndia | 5 January 2015 |
| 1000 tablet, film coated in 1 bottle | 65862-570-99 | Aurobindo PharmaIndia | 5 January 2015 |
| 100 tablet, film coated in 1 bottle | 55111-731-01 | Dr. Reddy's LaboratoriesIndia | 5 October 2021 |
| 500 tablet, film coated in 1 bottle | 55111-731-05 | Dr. Reddy's LaboratoriesIndia | 5 October 2021 |
| 30 tablet, film coated in 1 bottle | 55111-731-30 | Dr. Reddy's LaboratoriesIndia | 5 October 2021 |
| 60 tablet, film coated in 1 bottle | 55111-731-60 | Dr. Reddy's LaboratoriesIndia | 5 October 2021 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 55111-731-78 | Dr. Reddy's LaboratoriesIndia | 5 October 2021 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 59746-360-03 | Jubilant Cadista PharmaceuticalsIndia | 5 January 2015 |
| 500 tablet in 1 bottle | 59746-360-05 | Jubilant Cadista PharmaceuticalsIndia | 5 January 2015 |
| 30 tablet in 1 bottle | 59746-360-30 | Jubilant Cadista PharmaceuticalsIndia | 5 January 2015 |
| 90 tablet in 1 bottle | 59746-360-90 | Jubilant Cadista PharmaceuticalsIndia | 5 January 2015 |
| 500 tablet, film coated in 1 bottle | 42385-989-05 | Laurus LabsIndia | 22 April 2026 |
| 30 tablet, film coated in 1 bottle | 42385-989-30 | Laurus LabsIndia | 22 April 2026 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 42385-989-68 | Laurus LabsIndia | 22 April 2026 |
| 30 tablet, film coated in 1 bottle | 33342-062-07 | Macleods PharmaceuticalsIndia | 19 September 2016 |
| 1000 tablet, film coated in 1 bottle | 33342-062-44 | Macleods PharmaceuticalsIndia | 19 September 2016 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 23 December 1996 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Valsartan 40 mg tablet.
Other strengths and forms of Valsartan
Clinical summary
Valsartan is an angiotensin 2 receptor blocker indicated for hypertension, to lower blood pressure in adults and children 1 year and older, among other approved uses. It is available as tablets and oral solution. MedsAcross supplies Valsartan for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ValsartanFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Diovan prescribing information (Novartis Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Valsartan 40 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.